Novel dual HIV maintenance therapy with nevirapine plus lamivudine retain viral suppression through 144 weeks—A proof-of-concept study

por Kahlert, C. R., Cipriani, M., Vernazza, P.
Publicado 2020

Antibiotic-resistant pathogens in different patient settings and identification of surveillance gaps in Switzerland – a systematic review

por Fulchini, R., Albrich, W. C., Kronenberg, A., Egli, A., Kahlert, C. R., Schlegel, M., Kohler, P.
Publicado 2019

Humoral and cellular responses to mRNA-based COVID-19 booster vaccinations in patients with solid neoplasms under active treatment

por Su, E., S. Fischer, R. Demmer-Steingruber, Nigg, S., Güsewell, S., Albrich, W.C., Rothermundt, C., Silzle, T., Kahlert, C.R.
Publicado 2022